These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Prognostic Value of San S; Ravis E; Tessonier L; Philip M; Cammilleri S; Lavagna F; Norscini G; Arregle F; Martel H; Oliver L; Torras O; Renard S; Ambrosi P; Camoin L; Casalta AC; Hubert S; Casalta JP; Gouriet F; Riberi A; Avierinos JF; Lepidi H; Collart F; Raoult D; Drancourt M; Habib G J Am Coll Cardiol; 2019 Aug; 74(8):1031-1040. PubMed ID: 31439211 [TBL] [Abstract][Full Text] [Related]
46. Increased Prostate Cancer Glucose Metabolism Detected by Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897 [TBL] [Abstract][Full Text] [Related]
47. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival. Kim HR; Seo M; Nah YW; Park HW; Park SH Nucl Med Commun; 2018 Jul; 39(7):691-698. PubMed ID: 29893751 [TBL] [Abstract][Full Text] [Related]
48. The Utility of Chen H; Jin R; Wang Y; Li L; Li K; He Y Biomed Res Int; 2018; 2018():1823710. PubMed ID: 29686996 [TBL] [Abstract][Full Text] [Related]
49. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer. Seol HY; Kim YS; Kim SJ Oncology; 2021; 99(2):96-104. PubMed ID: 32980838 [TBL] [Abstract][Full Text] [Related]
50. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Metser U; Even-Sapir E Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153 [TBL] [Abstract][Full Text] [Related]
51. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients. Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912 [TBL] [Abstract][Full Text] [Related]
52. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937 [TBL] [Abstract][Full Text] [Related]
53. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129 [TBL] [Abstract][Full Text] [Related]
54. The diagnostic value of Kouijzer IJE; Scheper H; de Rooy JWJ; Bloem JL; Janssen MJR; van den Hoven L; Hosman AJF; Visser LG; Oyen WJG; Bleeker-Rovers CP; de Geus-Oei LF Eur J Nucl Med Mol Imaging; 2018 May; 45(5):798-805. PubMed ID: 29256136 [TBL] [Abstract][Full Text] [Related]
55. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark. Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234 [TBL] [Abstract][Full Text] [Related]
56. Performance of Laffon E; Marthan R Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):522-523. PubMed ID: 30377737 [No Abstract] [Full Text] [Related]
57. Reply: Fact Sheet About Interim and End-of-Treatment Kostakoglu L J Nucl Med; 2017 Jul; 58(7):1179. PubMed ID: 28385793 [No Abstract] [Full Text] [Related]